| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/30/2013 | EP2550254A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators |
| 01/30/2013 | EP2550063A1 Alr2 inhibitors and their synthesis from a natural source |
| 01/30/2013 | EP2549875A1 Soluble guanylate cyclase activators |
| 01/30/2013 | CN102906084A Compounds based on a triazole group that are capable of complexing at least one metallic element and coordination complex based on these compounds |
| 01/30/2013 | CN102906083A Novel substituted triazole derivatives as gamma secretase modulators |
| 01/30/2013 | CN102906080A Compounds for the treatment of hepatitis C |
| 01/30/2013 | CN102906074A Fused imidazole derivative |
| 01/30/2013 | CN102899032A Electropolymerizable fluorescent sensing material and application on fluorescent or electropolymerizable detection of metal ions |
| 01/30/2013 | CN102898481A Synthesis method for late transition metal complex catalyst |
| 01/30/2013 | CN102898418A Preparation method of esomeprazole magnesium |
| 01/30/2013 | CN102898417A Benzo-hexahydric nitrogenous heterocycle derivative |
| 01/30/2013 | CN102898416A 5-substituted quinazolinone derivatives as anti-cancer agents |
| 01/30/2013 | CN102898386A Quinazoline derivative, preparation method, intermediate, composition and application |
| 01/30/2013 | CN102898378A Phthalazinone derivatives and application thereof |
| 01/30/2013 | CN102898355A N-substituted Fagomine derivative and synthesizing method and applications thereof |
| 01/30/2013 | CN101553256B Phenylpropionamide compounds and the use thereof |
| 01/30/2013 | CN101316838B 1,1-dioxo-thiomorpholinyl indolyl methanone derivatives for use as h3 modulators |
| 01/30/2013 | CN101298451B Benzamide compounds and use thereof |
| 01/29/2013 | US8362274 Arylalkylamine compound and process for preparing the same |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362262 Compositions to effect neuronal growth |
| 01/29/2013 | US8362261 Process for preparing pyridyl-substituted pyrazoles |
| 01/29/2013 | US8362260 Crystalline forms of dexlansoprazole |
| 01/29/2013 | US8362259 Process for the preparation of esomeprazole magnesium in a stable form |
| 01/29/2013 | US8362258 Transition metal mediated oxidation of hetero atoms in organic molecules coordinated to transition metals |
| 01/29/2013 | US8362249 CXCR3 receptor antagonists |
| 01/29/2013 | US8362248 Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| 01/29/2013 | US8362247 Prokineticin 1 receptor antagonists |
| 01/29/2013 | US8362241 Inhibitors of PI3 kinase and/or mTOR |
| 01/29/2013 | US8362164 Multifunctional initiators for anionic polymerization and polymers therefrom |
| 01/29/2013 | US8362042 Stable R(+)-lansoprazole amine salt and a process for preparing the same |
| 01/29/2013 | US8362040 4-phenylpiperidine derivatives as renin inhibitors |
| 01/29/2013 | US8362038 1-isopropyl-2-oxo-1,2-dihydropyridine-3-carboxamide derivatives having 5-HT4 receptor agonistic activity |
| 01/29/2013 | US8362005 Monocyclic amide CGRP receptor antagonists |
| 01/29/2013 | US8362003 3-aminopyrrolidine derivatives as modulators of chemokine receptors |
| 01/29/2013 | US8362001 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/29/2013 | US8362000 Azetidinyl diamides as monoacylglycerol lipase inhibitors |
| 01/29/2013 | US8361994 Primary amine diazeniumdiolate heterocyclic derivatives |
| 01/29/2013 | CA2694410C Pyridinoylpiperidines as 5-ht1f agonists |
| 01/29/2013 | CA2570673C Compounds and methods for treating dyslipidemia |
| 01/29/2013 | CA2544492C Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties |
| 01/29/2013 | CA2460000C Inhibitors of glycogen synthase kinase-3 (gsk-3) for treating glaucoma |
| 01/24/2013 | WO2013012848A1 Benzamides |
| 01/24/2013 | WO2013012844A1 Arylpyrazole ethers as inhibitors of leukotriene a4 hydrolase |
| 01/24/2013 | WO2013012829A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2013012827A1 Diaminocyclohexane compounds and uses thereof |
| 01/24/2013 | WO2013012723A1 Novel 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors |
| 01/24/2013 | WO2013012485A2 Novel crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/24/2013 | WO2013012298A1 9h-carbazole compounds and electroluminescent devices involving them |
| 01/24/2013 | WO2013011402A1 Gpr 119 modulators |
| 01/24/2013 | WO2013011236A1 Novel complexing agents and corresponding lanthanide complexes |
| 01/24/2013 | WO2013011033A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | WO2013010881A1 NEW CRTh2 ANTAGONISTS |
| 01/24/2013 | WO2013010839A1 Novel and selective ccr2 antagonists |
| 01/24/2013 | WO2013010382A1 Heterocyclic substituted pyrimidine compound |
| 01/24/2013 | US20130023660 Carboxamide Compounds and Methods for Using the Same |
| 01/24/2013 | US20130023635 Catalysts based on heterocyclic-8-anilinoquinoline ligands |
| 01/24/2013 | US20130023611 Weakly Basic Hindered Amines Compounds Having Carbonate Skeletons, Synthetic Resin Compositions And Coating Compositions |
| 01/24/2013 | US20130023563 Amidinoaniline derivative |
| 01/24/2013 | US20130023548 Crystalline Forms of 4-Methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide |
| 01/24/2013 | US20130023541 Voltage-gated sodium channel blockers |
| 01/24/2013 | US20130023539 Pyrrolidine or thiazolidine carboxylic acid derivatives, pharmaceutical composition and methods for use in treating metabolic disorders as agonists of g-protein coupled receptor 43 (gpr43) |
| 01/24/2013 | US20130023534 Pyrazolyl-pyrimidines as kinase inhibitors |
| 01/24/2013 | US20130023533 New 5-alkynyl-pyridines |
| 01/24/2013 | US20130023532 Indazolyl-pyrimidines as kinase inhibitors |
| 01/24/2013 | US20130023528 Prolylhydroxylase inhibitors and methods of use |
| 01/24/2013 | US20130023527 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 01/24/2013 | US20130023525 Gyrase inhibitors and uses thereof |
| 01/24/2013 | US20130023522 Benzamides |
| 01/24/2013 | US20130023521 Novel selective inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
| 01/24/2013 | US20130023519 5-alkynyl-pyridines |
| 01/24/2013 | US20130023518 Novel 3,3-dimethyl tetrahydroquinoline derivatives |
| 01/24/2013 | US20130023503 Nk1 antagonists |
| 01/24/2013 | US20130023502 Substituted pyridinyl-pyrimidines and their use as medicaments |
| 01/24/2013 | US20130023497 Triazine Derivatives and their Therapeutical Applications |
| 01/24/2013 | US20130023495 Uses of dgat1 inhibitors |
| 01/24/2013 | US20130023494 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 01/24/2013 | US20130022594 Selective fak inhibitors |
| 01/24/2013 | US20130022587 Cycloalkyl-Substituted Imidazole Derivative |
| 01/24/2013 | US20130022578 Methods and system for interfering with viability of bacteria and related compounds and compositions |
| 01/24/2013 | CA2842352A1 3-(fluorvinyl)pyrazoles and the use thereof |
| 01/24/2013 | CA2842316A1 Novel crystalline forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 01/24/2013 | CA2841757A1 Gpr 119 modulators |
| 01/24/2013 | CA2834199A1 Benzamides |
| 01/23/2013 | EP2548874A2 Substituted piperazines as CB1 antagonists |
| 01/23/2013 | EP2548873A1 N-phenyl-dioxo-hydropyrimidines useful as hepatitis c virus (hcv) inhibitors |
| 01/23/2013 | EP2548872A1 Cyclopropanecarboxylic acid derivative |
| 01/23/2013 | EP2548865A1 Novel bis-indolic derivatives, their uses in particular as antibacterials |
| 01/23/2013 | EP2548863A1 New CRTh2 antagonists. |
| 01/23/2013 | EP2548618A2 Organic compounds |
| 01/23/2013 | EP2548439A1 Plant disease control agent |
| 01/23/2013 | EP2547671A1 Process for the preparation of highly pure crystalline imatinib base |
| 01/23/2013 | EP2547664A1 Morpholinylquinazolines |
| 01/23/2013 | EP2547662A1 Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists |
| 01/23/2013 | EP2547661A2 Indazole compounds and their uses |
| 01/23/2013 | EP2547656A1 Pyridine and pyrazine derivative for the treatment of cf |
| 01/23/2013 | EP2547655A2 Arylsulfonamide ccr3 antagonists |
| 01/23/2013 | CN1606545B Pyrrolidine and piperidine derivates as nk1 antagonists |
| 01/23/2013 | CN102892760A Prophylactic and/or therapeutic agent for non-alcoholic steatohepatitis |
| 01/23/2013 | CN102892759A Nitrogen-containing heterocyclic compound having kynurenine production inhibitory activity |